At the heart of this ecosystem is the AP3X token, which simplifies operations by eliminating the need for multiple assets, ...
In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...
AI Agents are rapidly transforming industries by automating routine tasks, making informed decisions, and unlocking new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results